All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for RECORDATI RARE DISEASES INC. · Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income · posted Apr 17, 2026

Official filing document

Lobbying activity 3

Medicare/Medicaid

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Health Issues

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Trade (domestic/foreign)

Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.